643 related articles for article (PubMed ID: 16477217)
21. The impact of sirolimus, mycophenolate mofetil, cyclosporine, azathioprine, and steroids on wound healing in 513 kidney-transplant recipients.
Flechner SM; Zhou L; Derweesh I; Mastroianni B; Savas K; Goldfarb D; Modlin CS; Krishnamurthi V; Novick A
Transplantation; 2003 Dec; 76(12):1729-34. PubMed ID: 14688524
[TBL] [Abstract][Full Text] [Related]
22. The combined effect of pre-transplant triglyceride levels and the type of calcineurin inhibitor in predicting the risk of new onset diabetes after renal transplantation.
Porrini E; Delgado P; Alvarez A; Cobo M; Pérez L; González-Posada JM; Hortal L; Gallego R; García JJ; Checa M; Morales A; Salido E; Hernández D; Torres A
Nephrol Dial Transplant; 2008 Apr; 23(4):1436-41. PubMed ID: 18029372
[TBL] [Abstract][Full Text] [Related]
23. Incidence of Posttransplantation Diabetes Mellitus in De Novo Kidney Transplant Recipients Receiving Prolonged-Release Tacrolimus-Based Immunosuppression With 2 Different Corticosteroid Minimization Strategies: ADVANCE, A Randomized Controlled Trial.
Mourad G; Glyda M; Albano L; Viklický O; Merville P; Tydén G; Mourad M; Lõhmus A; Witzke O; Christiaans MHL; Brown MW; Undre N; Kazeem G; Kuypers DRJ;
Transplantation; 2017 Aug; 101(8):1924-1934. PubMed ID: 27547871
[TBL] [Abstract][Full Text] [Related]
24. Clinical outcome in heart transplant recipients receiving everolimus in combination with dosage reduction of the calcineurin inhibitor cyclosporine A or tacrolimus.
Fuchs U; Zittermann A; Ensminger SM; Schulz U; Gummert JF
Transpl Immunol; 2014 Aug; 31(2):87-91. PubMed ID: 24932812
[TBL] [Abstract][Full Text] [Related]
25. Calcineurin inhibitor avoidance with daclizumab, mycophenolate mofetil, and prednisolone in DR-matched de novo kidney transplant recipients.
Asberg A; Midtvedt K; Line PD; Narverud J; Holdaas H; Jenssen T; Reisaeter AV; Johnsen LF; Fauchald P; Hartmann A
Transplantation; 2006 Jul; 82(1):62-8. PubMed ID: 16861943
[TBL] [Abstract][Full Text] [Related]
26. Trends in maintenance immunosuppressive drugs used in taiwanese kidney transplant recipients: an analysis of the national health insurance research database.
Tsai SF; Cheng CY; Shu KH; Wu MJ
Transplant Proc; 2012 Jan; 44(1):190-2. PubMed ID: 22310612
[TBL] [Abstract][Full Text] [Related]
27. Long-term follow-up of 100 high-risk renal transplant recipients converted from calcineurin inhibitors to sirolimus: a single center experience.
Halim MA; Al-Otaibi T; Johny KV; Hamid MH; Tawab KA; Balaha MA; Abraham M; Said T; Nair MP; Al-Waheeb S; Al-Muzairai I; Nampoory MR
Transplant Proc; 2009 Jun; 41(5):1666-70. PubMed ID: 19545704
[TBL] [Abstract][Full Text] [Related]
28. Steroid minimization in liver transplant recipients: impact on hepatitis C recurrence and post-transplant diabetes.
Humar A; Crotteau S; Gruessner A; Kandaswamy R; Gruessner R; Payne W; Lake J
Clin Transplant; 2007; 21(4):526-31. PubMed ID: 17645714
[TBL] [Abstract][Full Text] [Related]
29. Modifiable Variables Are Major Risk Factors for Posttransplant Diabetes Mellitus in a Time-Dependent Manner in Kidney Transplant: An Observational Cohort Study.
de Lucena DD; de Sá JR; Medina-Pestana JO; Rangel ÉB
J Diabetes Res; 2020; 2020():1938703. PubMed ID: 32258163
[TBL] [Abstract][Full Text] [Related]
30. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
[TBL] [Abstract][Full Text] [Related]
31. High impact of rejection therapy on the incidence of post-transplant diabetes mellitus after kidney transplantation.
Schweer T; Gwinner W; Scheffner I; Schwarz A; Haller H; Blume C
Clin Transplant; 2014 Apr; 28(4):512-9. PubMed ID: 24649873
[TBL] [Abstract][Full Text] [Related]
32. New-onset diabetes mellitus in kidney transplant recipients discharged on steroid-free immunosuppression.
Luan FL; Steffick DE; Ojo AO
Transplantation; 2011 Feb; 91(3):334-41. PubMed ID: 21242885
[TBL] [Abstract][Full Text] [Related]
33. Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial.
Zuckermann A; Reichenspurner H; Birsan T; Treede H; Deviatko E; Reichart B; Klepetko W
J Thorac Cardiovasc Surg; 2003 Apr; 125(4):891-900. PubMed ID: 12698153
[TBL] [Abstract][Full Text] [Related]
34. Calcineurin inhibitors in renal transplantation: what is the best option?
Tanabe K
Drugs; 2003; 63(15):1535-48. PubMed ID: 12887261
[TBL] [Abstract][Full Text] [Related]
35. Immunosuppression and Post-transplant Hyperglycemia.
Montero N; Pascual J
Curr Diabetes Rev; 2015; 11(3):144-54. PubMed ID: 25824238
[TBL] [Abstract][Full Text] [Related]
36. Incidence and risk factors of clinical characteristics, tacrolimus pharmacokinetics, and related genomic polymorphisms for posttransplant diabetes mellitus in the early stage of renal transplant recipients.
Numakura K; Satoh S; Tsuchiya N; Horikawa Y; Inoue T; Kakinuma H; Togashi H; Matsuura S; Tada H; Suzuki T; Habuchi T
Transplant Proc; 2005 May; 37(4):1865-7. PubMed ID: 15919487
[TBL] [Abstract][Full Text] [Related]
37. Posttransplant diabetes mellitus in kidney allograft recipients: incidence, risk factors, and management.
First MR; Gerber DA; Hariharan S; Kaufman DB; Shapiro R
Transplantation; 2002 Feb; 73(3):379-86. PubMed ID: 11884934
[TBL] [Abstract][Full Text] [Related]
38. Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs.
Lindenfeld J; Miller GG; Shakar SF; Zolty R; Lowes BD; Wolfel EE; Mestroni L; Page RL; Kobashigawa J
Circulation; 2004 Dec; 110(25):3858-65. PubMed ID: 15611389
[No Abstract] [Full Text] [Related]
39. Posttransplant diabetes mellitus after kidney transplantation with different immunosuppressive agents.
Romagnoli J; Citterio F; Violi P; Nanni G; Castagneto M
Transplant Proc; 2004 Apr; 36(3):690-1. PubMed ID: 15110632
[TBL] [Abstract][Full Text] [Related]
40. [Immunosuppression for kidney transplant recipients: current strategies].
Alberú J; Urrea EM
Rev Invest Clin; 2005; 57(2):213-24. PubMed ID: 16524061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
